Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H9N5O6.H2O |
Molecular Weight | 349.2557 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OC(=O)CN1C(=O)C(=O)NC2=CC(=C(C=C12)N3C=CN=C3)[N+]([O-])=O
InChI
InChIKey=OBHWTRBRRFQGRJ-UHFFFAOYSA-N
InChI=1S/C13H9N5O6.H2O/c19-11(20)5-17-8-4-9(16-2-1-14-6-16)10(18(23)24)3-7(8)15-12(21)13(17)22;/h1-4,6H,5H2,(H,15,21)(H,19,20);1H2
Zonampanel (also known as YM872) was developed as selective, potent and highly water-soluble competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist. Zonampanel possesses the neuroprotective effect against focal cerebral ischemia and participated in phase II clinical trials in acute stroke patients. However, because of the severe effects, including hallucinations, agitation, and catatonia the further studied were terminated.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model. | 2003 Apr 25 |
|
Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters. | 2004 Oct |
|
What lies behind serum urate concentration? Insights from genetic and genomic studies. | 2009 Dec 29 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00044057
YM872 (ZONAMPANEL) or placebo will be given as a continuous intravenous (iv) infusion for 24 hours
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
||
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C152963
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
CHEMBL119625
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
C110629
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
MM-48
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
11G3FV7PG7
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
300000034478
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
DTXSID30196900
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
9798437
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY | |||
|
466685-98-3
Created by
admin on Fri Dec 15 15:48:44 GMT 2023 , Edited by admin on Fri Dec 15 15:48:44 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD